Ozempic, Wegovy, and other GLP-1 weight loss drugs are doing some pretty gross things to people’s mouths —an unofficial side effect to the medication’s more official side effects, like gastrointestinal distress and dehydration . And, this year, the rise of “Ozempic breath” has gotten so bad that it’s starting to show up in market data. Hershey CEO Kirk Tanner told investors on Thursday that sales of the company’s breath-freshening gum brand Ice Breakers leapt up in early 2026, in an apparent response to halitosis cases induced by GLP-1 use. “Retail sales for our third-largest confection brand, Ice Breakers, increased over 8% in the quarter,” Tanner said in a pre-recorded message issued for the chocolate and confection maker’s Q1 earnings call this week, as reported by CNBC.…